Lb Pharmaceuticals Inc · NASDAQ:LBRX
Trails Edge Capital Partners, LP reported a 5.00% stake in Lb Pharmaceuticals Inc (Schedule 13G)
Event Dec 24, 2025 · Filed Dec 31, 2025
Trails Edge Capital Partners, LP reported a 5.00% stake in Lb Pharmaceuticals Inc, 1,268,265 shares, as a passive investor on Dec 24, 2025. Filed Dec 31, 2025 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 1,268,265
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Trails Edge Capital Partners, LP | 5.00% | 1,268,265 |
| Trails Edge Biotechnology Master Fund, LP | 5.00% | 1,268,265 |
| Ortav Yehudai | 5.00% | 1,268,265 |
Source
Related
- Lb Pharmaceuticals Inc
- Trails Edge Capital Partners, LP
- Lb Pharmaceuticals Inc shareholders
- Schedule 13G/A · JPMorgan Chase & Co · Oct 13, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G · JPMorgan Chase & Co · Jul 16, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · May 15, 2026